Kergoat H, Lovasik J V, Doughty M J
University of Waterloo, School of Optometry, Ontario, Canada.
J Ocul Pharmacol. 1989 Fall;5(3):199-216. doi: 10.1089/jop.1989.5.199.
A continuously recording high-resolution pupillometer was used to measure changes in pupil size and pupil reactivity to temporally modulated light, following topical application of a phenylephrine HCl 5%-tropicamide 0.8% combination mydriatic (Phenyltrope). A controlled light stimulus induced pupillary changes in the left eye while changes in the consensual pupillary responses were measured in the mydriatic-treated right eye. The effects on pupil light reactivity of a single drop of the combination mydriatic were also compared to those caused by one drop of tropicamide 1% alone. Phenyltrope was introduced onto the ophthalmic market ostensibly offering faster mydriasis because of its combined effect of both the parasympathetic and sympathetic innervation to the pupil. In the present study, we looked for any differences in the pupil reaction times and amplitudes as a function of time after drug administration, iris coloration and type of mydriatic instilled. Our results show that while the combination is a fast acting mydriatic providing a large and stable pupillary dilation in subjects with either blue or brown irides, it does not differ appreciably in efficacy from the mydriatic effect of tropicamide 1% alone in healthy subjects between 20 to 36 years of age. Applications of our findings to the clinical environment are presented.
使用连续记录的高分辨率瞳孔计,在局部应用5%盐酸去氧肾上腺素-0.8%托吡卡胺复方散瞳剂(复方托吡卡胺)后,测量瞳孔大小变化以及瞳孔对时间调制光的反应性。在左眼施加可控光刺激以诱导瞳孔变化,同时在使用散瞳剂治疗的右眼测量同感性瞳孔反应的变化。还比较了一滴复方散瞳剂对瞳孔光反应性的影响与单独一滴1%托吡卡胺所引起的影响。复方托吡卡胺进入眼科市场,表面上因其对瞳孔的副交感神经和交感神经双重支配作用而能更快地散瞳。在本研究中,我们探究了给药后不同时间、虹膜颜色以及所滴入散瞳剂类型对瞳孔反应时间和幅度的影响。我们的结果表明,虽然该复方制剂是一种起效迅速的散瞳剂,在蓝色或棕色虹膜受试者中能产生大且稳定的瞳孔扩张,但在20至36岁的健康受试者中,其散瞳效果与单独使用1%托吡卡胺相比并无明显差异。本文还阐述了我们的研究结果在临床环境中的应用。